{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:44:18Z","timestamp":1785905058229,"version":"3.56.0"},"reference-count":119,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SFB1315"],"award-info":[{"award-number":["SFB1315"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["FOR3004"],"award-info":[{"award-number":["FOR3004"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Status epilepticus is one of the most common life-threatening neurological emergencies in childhood with the highest incidence in the first 5\u2009years of life and high mortality and morbidity rates. Although it is known that a delayed treatment and a prolonged seizure can cause permanent brain damage, there is evidence that current treatments may be delayed and the medication doses administered are insufficient. Here, we summarize current knowledge on treatment of convulsive status epilepticus in childhood and propose a treatment algorithm. We performed a structured literature search <jats:italic>via<\/jats:italic> PubMed and <jats:uri>ClinicalTrails.org<\/jats:uri> and identified 35 prospective and retrospective studies on children &amp;lt;18 years comparing two and more treatment options for status epilepticus. The studies were divided into the commonly used treatment phases. As a first-line treatment, benzodiazepines buccal\/rectal\/intramuscular\/intravenous are recommended. For status epilepticus treated with benzodiazepine refractory, no superiority of fosphenytoin, levetirazetam, or phenobarbital was identified. There is limited data on third-line treatments for refractory status epilepticus lasting &amp;gt;30 min. Our proposed treatment algorithm, especially for children with SE, is for in and out-of-hospital onset aids to promote the establishment and distribution of guidelines to address the treatment delay aggressively and to reduce putative permanent neuronal damage. Further studies are needed to evaluate if these algorithms decrease long-term damage and how to treat refractory status epilepticus lasting &amp;gt;30 min.<\/jats:p>","DOI":"10.3389\/fneur.2023.1175370","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T04:35:15Z","timestamp":1688099715000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Treatment of pediatric convulsive status epilepticus"],"prefix":"10.3389","volume":"14","author":[{"given":"Lena-Luise","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gratopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian E.","family":"Elger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Kaindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yebeh.2014.05.018","article-title":"Comparison of pediatric patients with status epilepticus lasting 5-29 min versus >\/=30 min","volume":"37","author":"S\u00e1nchez Fern\u00e1ndez","year":"2014","journal-title":"Epilepsy Behav"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0140-6736(06)69043-0","article-title":"Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study","volume":"368","author":"Chin","year":"2006","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12028-013-9935-x","article-title":"The epidemiology of status epilepticus in the United States","volume":"20","author":"Dham","year":"2014","journal-title":"Neurocrit Care"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1542\/peds.83.3.323","article-title":"Low morbidity and mortality of status epilepticus in children","volume":"83","author":"Maytal","year":"1989","journal-title":"Pediatrics"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1474-4422(06)70546-4","article-title":"Outcome of paediatric convulsive status epilepticus: a systematic review","volume":"5","author":"Raspall-Chaure","year":"2006","journal-title":"Lancet Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/epi.14729","article-title":"Burden and epidemiology of status epilepticus in infants, children, and adolescents: a population-based study on German health insurance data","volume":"60","author":"Schubert-Bast","year":"2019","journal-title":"Epilepsia"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1212\/WNL.58.7.1070","article-title":"Incidence and mortality of generalized convulsive status epilepticus in California","volume":"58","author":"Wu","year":"2002","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1212\/WNL.0b013e3181d0cca2","article-title":"Prospective study of new-onset seizures presenting as status epilepticus in childhood","volume":"74","author":"Singh","year":"2010","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","article-title":"A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia","volume":"46","author":"DeLorenzo","year":"1996","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/epi.12307","article-title":"Treatment of convulsive status epilepticus in childhood: recommendations of the Italian league against epilepsy","volume":"54","author":"Capovilla","year":"2013","journal-title":"Epilepsia"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.seizure.2018.05.012","article-title":"Pediatric refractory and super-refractory status epilepticus","volume":"68","author":"Vasquez","year":"2019","journal-title":"Seizure"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus--report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/ana.1018","article-title":"How long do new-onset seizures in children last?","volume":"49","author":"Shinnar","year":"2001","journal-title":"Ann Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.seizure.2018.08.002","article-title":"Pathophysiology of convulsive status epilepticus","volume":"68","author":"Sanchez Fernandez","year":"2019","journal-title":"Seizure"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"CD001905","DOI":"10.1002\/14651858.CD001905.pub3","article-title":"Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children","volume":"2018","author":"McTague","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e1692","DOI":"10.1212\/WNL.0000000000005488","article-title":"Factors associated with treatment delays in pediatric refractory convulsive status epilepticus","volume":"90","author":"S\u00e1nchez Fern\u00e1ndez","year":"2018","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1212\/WNL.0000000000003550","article-title":"Refractory status epilepticus in children with and without prior epilepsy or status epilepticus","volume":"88","author":"S\u00e1nchez Fern\u00e1ndez","year":"2017","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1111\/epi.17043","article-title":"Benzodiazepine administration patterns before escalation to second-line medications in pediatric refractory convulsive status epilepticus","volume":"62","author":"Sheehan","year":"2021","journal-title":"Epilepsia"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/epi.16825","article-title":"Patterns of benzodiazepine underdosing in the established status epilepticus treatment trial","volume":"62","author":"Sathe","year":"2021","journal-title":"Epilepsia"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.seizure.2016.04.007","article-title":"Brain magnetic resonance in status epilepticus: a focused review","volume":"38","author":"Mendes","year":"2016","journal-title":"Seizure"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/epi.14499","article-title":"Neuroimaging of status epilepticus","volume":"59","author":"Meletti","year":"2018","journal-title":"Epilepsia"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1177\/0883073816638757","article-title":"A comparison of midazolam, lorazepam, and diazepam for the treatment of status epilepticus in children: a network meta-analysis","volume":"31","author":"Zhao","year":"2016","journal-title":"J Child Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40263-019-00690-8","article-title":"Pharmacotherapy for pediatric convulsive status epilepticus","volume":"34","author":"Singh","year":"2020","journal-title":"CNS Drugs"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2165\/11209350-000000000-00000","article-title":"Oromucosal midazolam: a guide to its use in paediatric patients with prolonged acute convulsive seizures","volume":"26","author":"Scott","year":"2012","journal-title":"CNS Drugs"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1542\/peds.2007-0930","article-title":"Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial","volume":"121","author":"Mpimbaza","year":"2008","journal-title":"Pediatrics"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.yebeh.2015.02.030","article-title":"Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: a systematic review with meta-analysis","volume":"49","author":"Brigo","year":"2015","journal-title":"Epilepsy Behav"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1553-2712.2010.00751.x","article-title":"Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis","volume":"17","author":"McMullan","year":"2010","journal-title":"Acad Emerg Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0140-6736(05)66909-7","article-title":"Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial","volume":"366","author":"McIntyre","year":"2005","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"106651","DOI":"10.1016\/j.eplepsyres.2021.106651","article-title":"A phase 3 open-label study of the efficacy, safety and pharmacokinetics of buccally administered midazolam hydrochloride for the treatment of status epilepticus in pediatric Japanese subjects","volume":"174","author":"Yoshinaga","year":"2021","journal-title":"Epilepsy Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejpn.2014.11.007","article-title":"Efficacy and safety of intramuscular midazolam versus rectal diazepam in controlling status epilepticus in children","volume":"19","author":"Momen","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0140-6736(98)06425-3","article-title":"Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial","volume":"353","author":"Scott","year":"1999","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ejpn.2010.05.009","article-title":"Efficacy and usability of buccal midazolam in controlling acute prolonged convulsive seizures in children","volume":"14","author":"Ashrafi","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/epi.13812","article-title":"Nonintravenous rescue medications for pediatric status epilepticus: a cost-effectiveness analysis","volume":"58","author":"Sanchez Fernandez","year":"2017","journal-title":"Epilepsia"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/088307380201700206","article-title":"Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study","volume":"17","author":"Fi\u015fgin","year":"2002","journal-title":"J Child Neurol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/PEC.0b013e3180328c92","article-title":"Prehospital intranasal midazolam for the treatment of pediatric seizures","volume":"23","author":"Holsti","year":"2007","journal-title":"Pediatr Emerg Care"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1177\/000992280504400904","article-title":"A comparison of buccal midazolam and rectal diazepam for the acute treatment of seizures","volume":"44","author":"Baysun","year":"2005","journal-title":"Clin Pediatr (Phila)"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3897\/folmed.63.e60938","article-title":"A comparative study on intranasal versus intravenous lorazepam in the Management of Acute Seizure in children","volume":"63","author":"Rudra","year":"2021","journal-title":"Folia Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40263-020-00720-w","article-title":"Efficacy, tolerability, and safety of concentrated intranasal midazolam spray as emergency medication in epilepsy patients during video-EEG monitoring","volume":"34","author":"von Blomberg","year":"2020","journal-title":"CNS Drugs"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.yebeh.2004.01.003","article-title":"Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children","volume":"5","author":"Mahmoudian","year":"2004","journal-title":"Epilepsy Behav"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1528-1167.2010.02949.x","article-title":"Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study","volume":"52","author":"Arya","year":"2011","journal-title":"Epilepsia"},{"key":"ref42","first-page":"1","article-title":"Intranasal midazolam compared with intravenous diazepam in patients suffering from acute seizure: a randomized clinical trial","volume":"22","author":"Javadzadeh","year":"2012","journal-title":"Iran J Pediatr"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/bmj.321.7253.83","article-title":"Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study","volume":"321","author":"Lahat","year":"2000","journal-title":"BMJ"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.braindev.2008.11.006","article-title":"Efficacy of buccal midazolam compared to intravenous diazepam in controlling convulsions in children: a randomized controlled trial","volume":"31","author":"Talukdar","year":"2009","journal-title":"Brain and Development"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40263-018-0544-2","article-title":"Use of emergency medication in adult patients with epilepsy: a multicentre cohort study from Germany","volume":"32","author":"Kadel","year":"2018","journal-title":"CNS Drugs"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(06)68696-0","article-title":"Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial","volume":"367","author":"Ahmad","year":"2006","journal-title":"Lancet"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/adc.87.3.225","article-title":"Respiratory depression in the acute management of seizures","volume":"87","author":"Stewart","year":"2002","journal-title":"Arch Dis Child"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12098-011-0505-y","article-title":"Intravenous diazepam, midazolam and lorazepam in acute seizure control","volume":"79","author":"Gathwala","year":"2012","journal-title":"Indian J Pediatr"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0387-7604(00)00116-9","article-title":"Midazolam as a first-line agent for status epilepticus in children","volume":"22","author":"Yoshikawa","year":"2000","journal-title":"Brain and Development"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acem.12596","article-title":"Accounting for repeat enrollments during an emergency clinical trial: the rapid anticonvulsant medications prior to arrival trial (RAMPART)","volume":"22","author":"Meurer","year":"2015","journal-title":"Acad Emerg Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/epi.12284","article-title":"Lessons from the RAMPART study--and which is the best route of administration of benzodiazepines in status epilepticus","volume":"54","author":"Silbergleit","year":"2013","journal-title":"Epilepsia"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/BF02724074","article-title":"Intramuscular midazolam vs intravenous diazepam for acute seizures","volume":"72","author":"Shah","year":"2005","journal-title":"Indian J Pediatr"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/00006565-199704000-00002","article-title":"A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children","volume":"13","author":"Chamberlain","year":"1997","journal-title":"Pediatr Emerg Care"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/epi.12905","article-title":"Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population","volume":"56","author":"Welch","year":"2015","journal-title":"Epilepsia"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/0887-8994(88)90083-5","article-title":"Lorazepam versus diazepam for the treatment of status epilepticus","volume":"4","author":"Giang","year":"1988","journal-title":"Pediatr Neurol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejpn.2009.02.004","article-title":"Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial","volume":"14","author":"Sreenath","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/jama.2014.2625","article-title":"Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial","volume":"311","author":"Chamberlain","year":"2014","journal-title":"JAMA"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1469-8749.1995.tb15014.x","article-title":"Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus","volume":"37","author":"Appleton","year":"1995","journal-title":"Dev Med Child Neurol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.yebeh.2016.09.020","article-title":"Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials","volume":"64","author":"Brigo","year":"2016","journal-title":"Epilepsy Behav"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S1474-4422(08)70141-8","article-title":"Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study","volume":"7","author":"Chin","year":"2008","journal-title":"Lancet Neurol"},{"key":"ref62","first-page":"415","article-title":"The treatment of convulsive status epilepticus in children. The status epilepticus working party, members of the status epilepticus working party","volume":"83","author":"Appleton","year":"2000","journal-title":"Arch Dis Child"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s13312-020-1754-5","article-title":"Efficacy, tolerability and serum phenytoin levels after intravenous Fosphenytoin loading dose in children with status epilepticus","volume":"57","author":"Srivastava","year":"2020","journal-title":"Indian Pediatr"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1212\/01.wnl.0000224880.35053.26","article-title":"Sodium valproate vs phenytoin in status epilepticus: a pilot study","volume":"67","author":"Misra","year":"2006","journal-title":"Neurology"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","article-title":"Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin","volume":"118","author":"Gilad","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/epi.17274","article-title":"International consensus on diagnosis and management of Dravet syndrome","volume":"63","author":"Wirrell","year":"2022","journal-title":"Epilepsia"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"e720","DOI":"10.1212\/WNL.0000000000012414","article-title":"Efficacy of home anticonvulsant Administration for Second-Line Status Epilepticus Treatment","volume":"97","author":"Wabl","year":"2021","journal-title":"Neurology"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3988\/jcn.2019.15.4.468","article-title":"Clinical efficacy and safety of injectable levetiracetam versus phenytoin as second-line therapy in the Management of Generalized Convulsive Status Epilepticus in children: An open-label randomized controlled trial","volume":"15","author":"Noureen","year":"2019","journal-title":"J Clin Neurol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial","volume":"393","author":"Dalziel","year":"2019","journal-title":"Lancet"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial","volume":"393","author":"Lyttle","year":"2019","journal-title":"Lancet"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized trial of three anticonvulsant medications for status epilepticus","volume":"381","author":"Kapur","year":"2019","journal-title":"N Engl J Med"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/jcph.1801","article-title":"Early exposure of Fosphenytoin, levetiracetam, and Valproic Acid after high-dose intravenous Administration in Young Children with Benzodiazepine-Refractory Status Epilepticus","volume":"61","author":"Sathe","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s13312-020-1755-4","article-title":"Comparison of phenytoin, valproate and levetiracetam in pediatric convulsive status epilepticus: a randomized double-blind controlled clinical trial","volume":"57","author":"Vignesh","year":"2020","journal-title":"Indian Pediatr"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12098-020-03221-2","article-title":"Clinical effectiveness of levetiracetam compared to Fosphenytoin in the treatment of benzodiazepine refractory convulsive status epilepticus","volume":"87","author":"Nalisetty","year":"2020","journal-title":"Indian J Pediatr"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.seizure.2015.03.018","article-title":"Intravenous levetiracetam in clinical practice--results from an independent registry","volume":"29","author":"Lang","year":"2015","journal-title":"Seizure"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40263-019-00652-0","article-title":"Intravenous brivaracetam in the treatment of status epilepticus: a systematic review","volume":"33","author":"Brigo","year":"2019","journal-title":"CNS Drugs"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/epi.16094","article-title":"Use of intravenous brivaracetam in status epilepticus: a multicenter registry","volume":"60","author":"Santamarina","year":"2019","journal-title":"Epilepsia"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/epi.14476","article-title":"Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus","volume":"59","author":"Strzelczyk","year":"2018","journal-title":"Epilepsia"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/epi.13267","article-title":"Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action","volume":"57","author":"Nicolas","year":"2016","journal-title":"Epilepsia"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24580","article-title":"Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT","volume":"24","author":"Appleton","year":"2020","journal-title":"Health Technol Assess"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.arcped.2021.09.011","article-title":"Comparison of the effect of continuous intravenous infusion of sodium valproate and midazolam on management of status epilepticus in children","volume":"28","author":"Abbaskhanian","year":"2021","journal-title":"Arch Pediatr"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","article-title":"Randomized study of intravenous valproate and phenytoin in status epilepticus","volume":"16","author":"Agarwal","year":"2007","journal-title":"Seizure"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ejpn.2012.01.012","article-title":"Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial","volume":"16","author":"Malamiri","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"ref85","volume-title":"StatPearls [Internet]","author":"Rahman","year":"2022"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41582-018-0101-0","article-title":"POLG-related disorders and their neurological manifestations","volume":"15","author":"Rahman","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern?","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00655.x","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"114","author":"Segura-Bruna","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/epi.13716","article-title":"Lacosamide in status epilepticus: systematic review of current evidence","volume":"58","author":"Strzelczyk","year":"2017","journal-title":"Epilepsia"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8432859","article-title":"Effectiveness and adverse effect of intravenous Lacosamide in nonconvulsive status epilepticus and acute repetitive seizures in children","volume":"2018","author":"Ngampoopun","year":"2018","journal-title":"Neurol Res Int"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.seizure.2016.01.008","article-title":"Intravenous lacosamide in clinical practice-results from an independent registry","volume":"39","author":"Lang","year":"2016","journal-title":"Seizure"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3109\/00207454.2015.1095743","article-title":"A comparison of four antiepileptic drugs in status epilepticus: experience from India","volume":"126","author":"Misra","year":"2016","journal-title":"Int J Neurosci"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.pediatrneurol.2008.01.001","article-title":"Treatment of refractory status epilepticus: literature review and a proposed protocol","volume":"38","author":"Abend","year":"2008","journal-title":"Pediatr Neurol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.spen.2014.12.006","article-title":"Status epilepticus and refractory status epilepticus management","volume":"21","author":"Abend","year":"2014","journal-title":"Semin Pediatr Neurol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/jcm5040047","article-title":"Management of Status Epilepticus in children","volume":"5","author":"Smith","year":"2016","journal-title":"J Clin Med"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12028-012-9790-1","article-title":"Treatment of status epilepticus: an international survey of experts","volume":"18","author":"Riviello","year":"2013","journal-title":"Neurocrit Care"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/PCC.0000000000000900","article-title":"Refractory status epilepticus in children: intention to treat with continuous infusions of midazolam and pentobarbital","volume":"17","author":"Tasker","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.seizure.2004.12.005","article-title":"Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus","volume":"14","author":"Ozdemir","year":"2005","journal-title":"Seizure"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1177\/08830738020170123002","article-title":"Eight-year study of childhood status epilepticus: midazolam infusion in management and outcome","volume":"17","author":"Koul","year":"2002","journal-title":"J Child Neurol"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.bja.2018.12.025","article-title":"Propofol infusion syndrome: a structured literature review and analysis of published case reports","volume":"122","author":"Hemphill","year":"2019","journal-title":"Br J Anaesth"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1212\/01.wnl.0000173066.89001.f9","article-title":"Propofol and thiopental for refractory status epilepticus in children","volume":"65","author":"van Gestel","year":"2005","journal-title":"Neurology"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1017\/cjn.2014.121","article-title":"Modern inhalational anesthetics for refractory status epilepticus","volume":"42","author":"Zeiler","year":"2015","journal-title":"Can J Neurol Sci"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pediatrneurol.2005.06.014","article-title":"Very-high-dose phenobarbital for childhood refractory status epilepticus","volume":"34","author":"Lee","year":"2006","journal-title":"Pediatr Neurol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1212\/WNL.38.7.1035","article-title":"Very-high-dose phenobarbital for refractory status epilepticus in children","volume":"38","author":"Mitchell","year":"1988","journal-title":"Neurology"},{"key":"ref106","first-page":"2597","article-title":"Very high dose phenobarbital for refractory status epilepticus","volume":"90","author":"Tiamkao","year":"2007","journal-title":"J Med Assoc Thail"},{"key":"ref107","first-page":"443","article-title":"A case of acute encephalitis with refractory repetitive partial seizures successfully controlled by very-high-dose phenobarbital therapy found in a boy","volume":"46","author":"Watanabe","year":"2014","journal-title":"No To Hattatsu"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s40263-016-0371-2","article-title":"(S)-ketamine in refractory and super-refractory status epilepticus: a retrospective study","volume":"30","author":"H\u00f6fler","year":"2016","journal-title":"CNS Drugs"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"e011565","DOI":"10.1136\/bmjopen-2016-011565","article-title":"Efficacy of ketamine in refractory convulsive status epilepticus in children: a protocol for a sequential design, multicentre, randomised, controlled, open-label, non-profit trial (KETASER01)","volume":"6","author":"Rosati","year":"2016","journal-title":"BMJ Open"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1212\/WNL.0b013e318278b685","article-title":"Efficacy and safety of ketamine in refractory status epilepticus in children","volume":"79","author":"Rosati","year":"2012","journal-title":"Neurology"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1177\/0883073807306248","article-title":"Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial","volume":"22","author":"Mehta","year":"2007","journal-title":"J Child Neurol"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ccc.2012.11.007","article-title":"Pediatric intensive care treatment of uncontrolled status epilepticus","volume":"29","author":"Wilkes","year":"2013","journal-title":"Crit Care Clin"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/MOP.0000000000000149","article-title":"Continuous infusion, general anesthesia and other intensive care treatment for uncontrolled status epilepticus","volume":"26","author":"Tasker","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"16","DOI":"10.14581\/jer.17003","article-title":"Could cannabidiol be a treatment option for intractable childhood and adolescent epilepsy?","volume":"7","author":"Koo","year":"2017","journal-title":"J Epilepsy Res"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.2174\/1381612823666170809101517","article-title":"Ketogenic diets in the treatment of epilepsy","volume":"23","author":"Elia","year":"2017","journal-title":"Curr Pharm Des"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/epi.14022","article-title":"New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): state of the art and perspectives","volume":"59","author":"Gaspard","year":"2018","journal-title":"Epilepsia"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/ana.25008","article-title":"Brexanolone as adjunctive therapy in super-refractory status epilepticus","volume":"82","author":"Rosenthal","year":"2017","journal-title":"Ann Neurol"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.3390\/jcm9072220","article-title":"Rapid whole-exome sequencing as a diagnostic tool in a neonatal\/pediatric intensive care unit","volume":"9","author":"\u015amigiel","year":"2020","journal-title":"J Clin Med"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1175370\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T04:35:24Z","timestamp":1688099724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1175370\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":119,"alternative-id":["10.3389\/fneur.2023.1175370"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1175370","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"article-number":"1175370"}}